Are Pot Stocks Like Aurora Cannabis (TSX:ACB) and Hexo (TSX:HEXO) Running Out of Cash?

Aurora Cannabis and Hexo will have to infuse capital by the end of 2020 to keep operations going.

| More on:

We know that cannabis companies have been struggling with structural and regulatory issues for a while. Most pot companies have reported less-than-impressive quarterly results over the last year, resulting in an extended bear run for investors.

The recreational marijuana industry has been rattled by illegal sales that still account for 40% of total Canadian cannabis sales. The slower-than-expected roll-out of retail stores in major provinces have resulted in high inventory levels.

Further, high capital expenditures and related investments have meant that pot companies are struggling to stay afloat and might very well run out of cash. According to a report from boutique investment bank Ello Capital, several cannabis companies, including heavyweights such as Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Hexo (TSX:HEXO)(NYSE:HEXO), would need to raise additional capital sooner rather than later.

Several pot stocks are still reporting a negative EBITDA and operating cash flow. This suggests it will be difficult for companies to raise debt, forcing them to raise additional equity capital and resulting in the dilution of existing shareholder capital.

Aurora Cannabis

According to Ello Capital, Aurora Cannabis has about 2.3 months of leeway left before its cash balance is down to zero. Aurora ended the December quarter with a cash balance of $182.5 million. It has a total debt of $602 million, while its operating cash flow stands at -$288.9 million and free cash flow is at -$695 million.

Aurora Cannabis is grappling with several other issues. It announced the exit of founder and CEO Terry Booth recently. The company also had to stop construction for two key projects and announced close to $1 billion in balance sheet write-offs.

Aurora Cannabis stock has been pummeled in the last year. The stock is trading 84% below its 52-week high, and now with liquidity concerns, there is a chance that investors will continue to bleed in 2020 as well.

The massive correction for Aurora Cannabis has meant the stock is trading at a price-to-book ratio of 0.66. With a market cap of $2.55 billion, it is valued at 8.35 times forward sales.

Hexo is down 83% from 52-week high

Hexo is another company under the scanner. Ello Capital estimated Hexo’s cash balance to be enough for 6.5 months. Hexo already has raised about $100 million since October last year by equity offerings as well as convertible debentures.

Hexo ended the October quarter with a cash balance of $65.4 million. It has a total debt of $55 million, while its operating cash flow stands at -$138 million and free cash flow at -$246 million.

Hexo stock too has burnt investor wealth. The stock is currently trading 83% below its 52-week high. Shares fell 20% in January 2020 after Hexo’s acquisition of Newstrike came under the scanner. Newstrike was reportedly growing cannabis products illegally at its Beamsville facility in Niagara.

In fiscal 2020, Hexo aims to reduce operating expenses by 25%. Like most pot companies, Hexo is also banking on Cannabis 2.0 to drive product demand higher. Its partnership with Molson Coors can also help Hexo to stay afloat, which will give the firm a chance to make a comeback.

The verdict

There is a chance that Aurora, Hexo, and others may be able to issue additional capital in the upcoming months. However, there is also a chance that these companies will crash and burn considering the current pessimism surrounding pot stocks.

The cannabis industry is still at a nascent stage and can be likened to the dot com bubble of 2000. While Amazon and Alphabets’s Google rose from the ashes to generate millions of dollars in returns, there were hundreds of internet stocks that were wiped out without a trace.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. David Gardner owns shares of Alphabet (A shares), Alphabet (C shares), and Amazon. Tom Gardner owns shares of Alphabet (A shares) and Alphabet (C shares). The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), and Amazon. The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »